Organ transplantation remains the treatment of choice for patients with total loss of function in a life-sustaining organ. The use of various immunosuppressive drugs, including calcineurin inhibitors, contributes to improved clinical outcomes by suppressing T-cell-mediated graft rejection [1]. However, the complete rejection management remains to be elucidated. Even if T cell-mediated rejection can...

Iguchi Kazuhito et al.
Journal of Cardiothoracic Surgery 2024; 19(1): 367
Lire la suite

One of the most crucial elements for long-term peri-implant stability is establishing sufficient supra-crestal soft tissue seal and an adequate band of keratinized attached tissue. This soft tissue barrier protects the underlying bone from microbial invasion and subsequent peri-implant diseases [1]. Over the past five decades, free gingival graft (FGG) has been widely used as the most documented and...

Moslemi Neda et al.
Journal of Medical Case Reports 2024; 18(1): 291
Lire la suite

Kidney transplantation (KT) is the treatment of choice for patients with end-stage renal disease, offering improved survival and quality of life for the vast majority of patients when compared to other renal replacement therapies [1]. Despite improving patient and graft survival rates over time, the morbidity and mortality associated with postoperative complications remain a significant clinical concern...

Minkovich Michelle et al.
BMC Surgery 2024; 24(1): 165
Lire la suite